University of Illinois

The company is aiming to uncover the cause of fibromyalgia and to identify new disease-specific genetic biomarkers.

By sequencing ancient and contemporary indigenous individuals from Canada's Pacific Coast, researchers uncovered clues to a post-colonization population bottleneck.

Using thousands of old samples, researchers explored the historical context for rising presence of the Nosema bombi fungal pathogen in wild bumble bee populations.

A team of scientists believe that exosomal miRNAs holds promise to be significant biomarkers for Alzheimer's disease. 

A proteomic and phylogenomic analysis places viruses on a universal tree of life and suggests that they evolved in parallel with modern cells.

With genome sequences from 10 bee species, researchers unearthed regulatory changes contributing to more complex social systems in the insects.

A study has demonstrated why dosing algorithms for warfarin have performed poorly in patients with African ancestry, especially in recent randomized clinical trials.

NEW YORK (GenomeWeb News) – A multidisciplinary team of researchers at the Institute for Genomic Biology, a University of Illinois research center, will use $3 million in funding from the Simons Foundation to search for the genetic foundations of social behavior across varying species, IGB said t

Samsung Electronics of Seoul, South Korea, has received US Patent No. 8,469,492, "Method of printing droplet using capillary electric charge concentration." The method relies on a capillary nozzle that consists of a back end and a front end.

NEW YORK (GenomeWeb News) – The Roy J. Carver Charitable Trust today announced it has awarded $2 million to the Institute for Genomic Biology at the University of Illinois at Urbana-Champaign to support research into synthetic biology.


An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.